Xstelos Holdings, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | |
|---|---|---|
| Revenue | — | $25.2M |
| Operating income | $18.3M | — |
| Net income | $34.0M | — |
| Total assets | $115.6M | — |
| Total liabilities | $51.7M | — |
| Equity | $62.0M | — |
| EPS (diluted) | $1.88 | — |
| Shares out. | 24.2M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- —
- Net margin
- —
- Return on equity
- 54.8%
- Return on assets
- 29.4%
- Return on capital (ROCE)
- 18.5%
- Liabilities / assets
- 44.7%
- Debt / equity
- 0.83×
- Book value / share
- $2.56
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Altman Z″ (distress)
- 3.88safe
- Accruals / assets
- 17.4%high accruals
- Piotroski F-Score
- 2/3weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High accruals — earnings-quality risk
- Strong return on equity (>15%)
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 15, 2013
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Shareholder vote · Other material eventDec 24, 2013
- Other material eventDec 18, 2013
- Other material eventDec 5, 2013
- Other material eventSep 5, 2013
- Regulation FD disclosure · Other material eventJan 29, 2013
- Regulation FD disclosure · Other material eventJan 3, 2013
- Director / officer changeDec 24, 2012
- Other material eventDec 10, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTMar 5, 2014
- 15-12GDec 24, 2013
- 8-KDec 24, 2013
- SC 13E3/ADec 24, 2013
- 8-KDec 18, 2013
- SC 13E3/ADec 13, 2013
- DEFA14ADec 13, 2013
- 8-KDec 5, 2013
- SC 13E3/ANov 25, 2013
- DEFA14ANov 25, 2013
- DEF 14ANov 22, 2013
- SC 13E3/ANov 22, 2013
- NT 10-QNov 15, 2013
- 10-Q/AFORM 10-Q/ANov 15, 2013
- 10-QFORM 10-QNov 14, 2013
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.